Phase 2 BRAF V600E Mutation Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

Stage IV Colorectal Cancer Positive for BRAF V600E Mutation

Northwestern University43 enrolled1 locationNCT05576896

Recruiting

Phase 2

Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma

BRAF V600E Mutation PositiveAmeloblastoma

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University12 enrolled1 locationNCT06653517